EcoDrugPlus

Tachykinin Receptor 1

Ensembl ID : ENSAPOG00000023965
Gene Symbol: TACR1
3 Cross references
214 Possible Orthologues:

Tachykinin Receptor 2

Ensembl ID : ENSAPOG00000011915
Gene Symbol: TACR2
3 Cross references
200 Possible Orthologues:

Tachykinin Receptor 3

Ensembl ID : ENSAPOG00000007324
Gene Symbol: TACR3
3 Cross references
172 Possible Orthologues:

Telomerase Reverse Transcriptase

Ensembl ID : ENSAPOG00000020553
Gene Symbol: TERT
3 Cross references
188 Possible Orthologues:

Thromboxane A Synthase 1

Ensembl ID : ENSAPOG00000023465
Gene Symbol: TBXAS1
3 Cross references
220 Possible Orthologues:

Thromboxane A2 Receptor

Ensembl ID : ENSAPOG00000014644
Gene Symbol: TBXA2R
3 Cross references
193 Possible Orthologues:

Thymidine Phosphorylase

Ensembl ID : ENSAPOG00000008710
Gene Symbol: TYMP
4 Cross references
173 Possible Orthologues:

Thymidylate Synthetase

Ensembl ID : ENSAPOG00000017049
Gene Symbol: TYMS
3 Cross references
225 Possible Orthologues:

Thyroid Hormone Receptor Beta

Ensembl ID : ENSAPOG00000015392
Gene Symbol: THRB
3 Cross references
390 Possible Orthologues:

Thyrotropin Releasing Hormone Receptor

Ensembl ID : ENSAPOG00000004116
Gene Symbol: TRHR
1 Cross references
203 Possible Orthologues:

Thyrotropin-Releasing Hormone Receptor-Like

Ensembl ID : ENSAPOG00000014719
Gene Symbol: LOC110960909
3 Cross references
194 Possible Orthologues:

Tissue Factor-Like

Ensembl ID : ENSAPOG00000008017
Gene Symbol: LOC110961074
2 Cross references
171 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).